Metastin derivatives and use thereof

Details for Australian Patent Application No. 2005257484 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Nishizawa, Naoki; Asami, Taiji; Kitada, Chieko

Agent Griffith Hack

Pub. Number AU-A-2005257484

PCT Pub. Number WO2006/001499

Priority 2004-187671 25.06.04 JP; 2004-363311 15.12.04 JP

Filing date 23 June 2005

Wipo publication date 5 January 2006

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/001499 Priority application(s): WO2006/001499

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005257486-Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as CRF antagonists

2005257483-Method for producing (Z)-1-phenyl-1-diethylaminocarbonyl-2hydroxymethyl cyclopropane